Company Analysis

Avita Medical, Inc. (RCEL)

Nasdaq: RCEL · Surgical & Medical Instruments & Apparatus · Valencia, CA · filing with the SEC since 2018
Grade5.3
◀ Past 6.6● Present 4.3▶ Future 5.3
1 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2021FY 2020FY 2019FY 2018
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018
Report filedFeb 12, 2026Feb 13, 2025Feb 22, 2024Feb 23, 2023Feb 28, 2022Aug 26, 2021Aug 27, 2020Oct 31, 2019·
Revenue71,61064,25150,14334,421·29,23214,2635,474929
For lenders
Provision for credit losses-102324-5·1243615
Cost of revenue12,7949,0947,7806,041·5,9492,9731,271546
Gross profit58,81655,15742,36328,380·23,28311,2904,203383
Research and development20,83920,36020,82113,857·14,8189,164r8,004r6,257
Sales and marketing53,13858,19537,29121,913·14,66015,706r12,549r4,875
General and administrative27,37333,19528,33423,330·22,40033,025r15,099r9,403
Total operating expenses101,350111,75086,44659,100·51,87857,89535,65221,958
Operating income-42,534-56,593-42,655-27,505·-26,540-42,679-25,528-13,841
Interest expense5,0045,3611,14316·22332721
Other income (expense), net-1,0381638,483892·····
Income before income taxes-48,576-61,791-35,315-26,629·-26,545-42,026-25,223-13,809
Income tax expense11546636·384-121-1,074
Net income-48,587-61,845-35,381-26,665·-26,583-42,030-25,102-12,735
Earnings per share, basic-1.74-2.39-1.40r1.07·1.172.071.561.37
Earnings per share, diluted-1.74-2.39-1.40r1.07·1.172.071.561.37
Weighted average shares, basic27,860,78425,883,05625,331,26425,000,180·22,674,31320,290,96616,064,5889,326,810
Weighted average shares, diluted27,860,78425,883,05625,331,26425,000,180·22,674,31320,290,96616,064,5889,326,810
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Provision for credit losses set aside for loans that may not be repaidus-gaap:ProvisionForLoanLeaseAndOtherLosses
us-gaap:ProvisionForLoanAndLeaseLosses
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton RCEL · research, not advice